UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR

Molecular cancer therapeutics, 2017-08, Vol.16 (8), p.1470-1486

2017

Volltextzugriff (PDF)

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

Scientific reports, 2017-11, Vol.7 (1), p.14674-17, Article 14674

2017

Volltextzugriff (PDF)

Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells

Cancers, 2021-01, Vol.13 (2), p.166

2021

Volltextzugriff (PDF)

Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery

Advances in cancer research, 2018-01, Vol.137, p.115-170

2018

Volltextzugriff (PDF)

Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment

Topics in current chemistry (2016), 2017-04, Vol.375 (2), Article 35

2017

Volltextzugriff (PDF)

Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment

Nanomedicine, 2018-02, Vol.14 (2), p.373-384

2018

Volltextzugriff (PDF)

Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells

Scientific reports, 2016-12, Vol.6 (1), p.38541, Article 38541

2016

Volltextzugriff (PDF)

Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells

Molecular pharmaceutics, 2014-08, Vol.11 (8), p.2720-2733

2014

Volltextzugriff (PDF)

HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells

Scientific reports, 2017-08, Vol.7 (1), p.9694-11, Article 9694

2017

Volltextzugriff (PDF)

Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration

Journal of nanobiotechnology, 2016-06, Vol.14 (1), p.47, Article 47

2016

Volltextzugriff (PDF)

HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer

Cancer gene therapy, 2015-12, Vol.22 (12), p.581-590

2015

Volltextzugriff (PDF)

HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy

Oncotarget, 2016-10, Vol.7 (40), p.64820-64835

2016

Volltextzugriff (PDF)

Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy

International journal of nanomedicine, 2015-01, Vol.10 (default), p.6773-6788

2015

Volltextzugriff (PDF)

Abstract 5418: Tumor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and cell migration

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5418-5418

2014

Volltextzugriff (PDF)

Abstract 3810: ARID1A is a novel HuR target: Implications in breast cancer radiotherapy

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3810-3810

2016

Volltextzugriff (PDF)

IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells

Oncotarget, 2016-10, Vol.7 (43), p.70247-70263

2016

Volltextzugriff (PDF)

Abstract 3738: IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3738-3738

2016

Volltextzugriff (PDF)

Abstract 3943: siRNA-mediated HuR silencing sensitizes triple-negative breast cancer cells to radiation therapy

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3943-3943

2014

Volltextzugriff (PDF)

489. Tumor-Targeted Hursirna-Nanoparticle Delivery Inhibits Lung Tumor Growth In Vitro and In Vivo

Molecular therapy, 2016-05, Vol.24, p.S194-S194

2016

Volltextzugriff (PDF)

Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity

Oncotarget, 2015-06, Vol.6 (18), p.16271-16286

2015

Volltextzugriff (PDF)

Abstract 3306: The RNA-binding protein HuR radiosensitizes human TNBC cells by modulating the cellular response to DNA damage and oxidative stress

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3306-3306

2015

Volltextzugriff (PDF)

Abstract 5249: Functional importance of IL-24 phosphorylation in regulating molecular signaling pathways associated with cancer cell survival and metastasis

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5249-5249

2013

Volltextzugriff (PDF)

Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment

Polymeric Gene Delivery Systems, 2018, p.233-255

2018

Volltextzugriff (PDF)

Lipid Nanocarriers for RNAi-Based Cancer Therapy

Molecular Medicines for Cancer, 2019, Vol.1, p.449-472

1, 2019

Volltextzugriff (PDF)

Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy

IEEE transactions on nanobioscience, 2016-12, Vol.15 (8), p.849-863

2016

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells

Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery

Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment

Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment

Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells

Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells

HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells

Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration

HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer

HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy

Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy

Abstract 5418: Tumor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and cell migration

Abstract 3810: ARID1A is a novel HuR target: Implications in breast cancer radiotherapy

IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells

Abstract 3738: IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells

Abstract 3943: siRNA-mediated HuR silencing sensitizes triple-negative breast cancer cells to radiation therapy

489. Tumor-Targeted Hursirna-Nanoparticle Delivery Inhibits Lung Tumor Growth In Vitro and In Vivo

Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity

Abstract 3306: The RNA-binding protein HuR radiosensitizes human TNBC cells by modulating the cellular response to DNA damage and oxidative stress

Abstract 5249: Functional importance of IL-24 phosphorylation in regulating molecular signaling pathways associated with cancer cell survival and metastasis

Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment

Lipid Nanocarriers for RNAi-Based Cancer Therapy

Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy

Suchergebnisse filtern